Skip to main content

Find Clinical Trials

Home
Conditions
EBV Infection After Allogenic HSCT

Clinical trial condition

EBV Infection After Allogenic HSCT

Explore clinical trials studying EBV Infection After Allogenic HSCT. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

EBV Infection After Allogenic HSCT trial results

Recruiting

Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT07693881

Conditions: EBV Infection After Allogenic HSCT
Locations: Nanfang Hospital, Southern Medical University Guangzhou, China

View Trial Details

Recruiting

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

NCT06119256

Conditions: DNA Virus Infections, EBV Infection After Allogenic HSCT, Epstein-Barr Virus Infections, +4 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details